Literature DB >> 18503215

Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city.

Yasuyuki Iguchi1, Kazumi Kimura, Junya Aoki, Kazuto Kobayashi, Yuka Terasawa, Kenichiro Sakai, Kensaku Shibazaki.   

Abstract

BACKGROUND: A community-based study was conducted to estimate the prevalence of atrial fibrillation (AF) in Japanese adults aged >or=40 years in Kurashiki-city and to examine associated risk factors. METHODS AND
RESULTS: Adult residents (>or=40-year-old) were examined in the Kurashiki-city Annual Medical Survey (KAMS) provided by the Kurashiki-city Public Health Center from May to December 2006. KAMS consisted of medical interviews, physical examination, blood testing and electrocardiography to assess the presence of AF. All participants were divided into AF and non-AF groups, their clinical characteristics compared, and the risk factors associated with AF investigated. Of 246,246 adult residents, 41,436 (age: 72.1+/-11.3 years; 13,963 men) underwent the KAMS. Estimated overall prevalence of AF was 1.6%. Multivariate analysis demonstrated that AF was independently associated with cardiac disease (odds ratio (OR), 9.00; 95% confidence interval (CI), 7.65-10.6; p<0.001), chronic kidney disease (OR, 1.76; 95%CI, 1.49-2.07; p<0.001), male sex (OR, 1.59; 95%CI, 1.34-1.85; p<0.001), and diabetes mellitus (OR, 1.46; 95%CI, 1.20-1.78; p<0.001). Hypercholesterolemia was highly associated with the absence of AF (OR, 0.54; 95%CI, 0.45-0.64, p<0.001).
CONCLUSIONS: Prevalence of AF in Japan is approximately 1.6%, lower than that in Western populations. Male sex, and cardiac and chronic kidney diseases are associated with the presence of AF.

Entities:  

Mesh:

Year:  2008        PMID: 18503215     DOI: 10.1253/circj.72.909

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  43 in total

Review 1.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

Review 2.  Left atrial function in diabetes: does it help?

Authors:  Marijana Tadic; Cesare Cuspidi
Journal:  Acta Diabetol       Date:  2020-06-09       Impact factor: 4.280

Review 3.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

4.  Prediction of Atrial Fibrillation by B-type Natriuretic Peptide.

Authors:  Hiroyuki Takase; Yasuaki Dohi; Hiroo Sonoda; Genjiro Kimura
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 5.  Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.

Authors:  Jared W Magnani; Michiel Rienstra; Honghuang Lin; Moritz F Sinner; Steven A Lubitz; David D McManus; Josée Dupuis; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2011-11-01       Impact factor: 29.690

6.  Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese.

Authors:  Steven A Lubitz; Kathryn L Lunetta; Honghuang Lin; Dan E Arking; Stella Trompet; Guo Li; Bouwe P Krijthe; Daniel I Chasman; John Barnard; Marcus E Kleber; Marcus Dörr; Kouichi Ozaki; Albert V Smith; Martina Müller-Nurasyid; Stefan Walter; Joanne M Murabito; Moritz F Sinner; Vilmundur Gudnason; Stephan B Felix; Winfried März; Mina Chung; Christine M Albert; Bruno H Stricker; Toshihiro Tanaka; Susan R Heckbert; J Wouter Jukema; Alvaro Alonso; Emelia J Benjamin; Patrick T Ellinor; Sunil K Agarwal; Joshua C Bis; Jennifer A Brody; Lin Y Chen; Brendan M Everett; Ian Ford; Oscar H Franco; Tamara B Harris; Albert Hofman; Stefan Kääb; Saagar Mahida; Sekar Kathiresan; Michiaki Kubo; Lenore J Launer; Peter W MacFarlane; Jared W Magnani; Barbara McKnight; David D McManus; Annette Peters; Bruce M Psaty; Lynda M Rose; Jerome I Rotter; Guenther Silbernagel; Jonathan D Smith; Nona Sotoodehnia; David J Stott; Kent D Taylor; Andreas Tomaschitz; Tatsuhiko Tsunoda; Andre G Uitterlinden; David R Van Wagoner; Uwe Völker; Henry Völzke
Journal:  J Am Coll Cardiol       Date:  2014-01-30       Impact factor: 24.094

7.  Atrial fibrillation and diabetes mellitus. Correlation, co-existence, and coagulation therapy.

Authors:  B Stratmann; D Tschöpe
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

Review 8.  Primary and key secondary results from the ROCKET AF trial, and their implications on clinical practice.

Authors:  Rohan Shah; Manesh R Patel
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-09-19

9.  Diabetes mellitus, glycemic control, and risk of atrial fibrillation.

Authors:  Sascha Dublin; Nicole L Glazer; Nicholas L Smith; Bruce M Psaty; Thomas Lumley; Kerri L Wiggins; Richard L Page; Susan R Heckbert
Journal:  J Gen Intern Med       Date:  2010-04-20       Impact factor: 5.128

10.  Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).

Authors:  Naoki Saji; Kazumi Kimura; Yohei Tateishi; Shigeru Fujimoto; Nobuyuki Kaneko; Takao Urabe; Akira Tsujino; Yasuyuki Iguchi
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.